[go: up one dir, main page]

RU2008116176A - Стимулятор секреции глюкагон-подобного пептида 1, продукты питания или напитки, стимулирующие секрецию глюкагон-подобного пептида 1, ингибитор постпрандиальной гипергликемии и продукта питания или напитки, ингибирующие постпрандиальную гипергликемию - Google Patents

Стимулятор секреции глюкагон-подобного пептида 1, продукты питания или напитки, стимулирующие секрецию глюкагон-подобного пептида 1, ингибитор постпрандиальной гипергликемии и продукта питания или напитки, ингибирующие постпрандиальную гипергликемию Download PDF

Info

Publication number
RU2008116176A
RU2008116176A RU2008116176/15A RU2008116176A RU2008116176A RU 2008116176 A RU2008116176 A RU 2008116176A RU 2008116176/15 A RU2008116176/15 A RU 2008116176/15A RU 2008116176 A RU2008116176 A RU 2008116176A RU 2008116176 A RU2008116176 A RU 2008116176A
Authority
RU
Russia
Prior art keywords
glucagon
peptide
secretion
inhibitor
postprandial
Prior art date
Application number
RU2008116176/15A
Other languages
English (en)
Other versions
RU2388485C2 (ru
Inventor
Йоусуке ИТОХ (JP)
Йоусуке ИТОХ
Коудзи НОМАГУТИ (JP)
Коудзи НОМАГУТИ
Мунео ЯМАДА (JP)
Мунео ЯМАДА
Original Assignee
Моринага Милк Индастри Ко., Лтд. (Jp)
Моринага Милк Индастри Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Моринага Милк Индастри Ко., Лтд. (Jp), Моринага Милк Индастри Ко., Лтд. filed Critical Моринага Милк Индастри Ко., Лтд. (Jp)
Publication of RU2008116176A publication Critical patent/RU2008116176A/ru
Application granted granted Critical
Publication of RU2388485C2 publication Critical patent/RU2388485C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A23J1/202—Casein or caseinates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

1. Лекарственный стимулятор секреции глюкагон-подобного пептида 1, содержащий κ-казеин в качестве активного ингредиента. ! 2. Лекарственный ингибитор постпрандиальной гипергликемии, содержащий κ-казеин в качестве активного ингредиента.

Claims (2)

1. Лекарственный стимулятор секреции глюкагон-подобного пептида 1, содержащий κ-казеин в качестве активного ингредиента.
2. Лекарственный ингибитор постпрандиальной гипергликемии, содержащий κ-казеин в качестве активного ингредиента.
RU2008116176/15A 2005-09-30 2006-09-29 Стимулятор секреции глюкагон-подобного пептида 1, продукты питания или напитки, стимулирующие секрецию глюкагон-подобного пептида 1, ингибитор постпрандиальной гипергликемии и продукты питания или напитки, ингибирующие постпрандиальную гипергликемию RU2388485C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005-288338 2005-09-30
JP2005288338 2005-09-30

Publications (2)

Publication Number Publication Date
RU2008116176A true RU2008116176A (ru) 2009-10-27
RU2388485C2 RU2388485C2 (ru) 2010-05-10

Family

ID=37899833

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2008116176/15A RU2388485C2 (ru) 2005-09-30 2006-09-29 Стимулятор секреции глюкагон-подобного пептида 1, продукты питания или напитки, стимулирующие секрецию глюкагон-подобного пептида 1, ингибитор постпрандиальной гипергликемии и продукты питания или напитки, ингибирующие постпрандиальную гипергликемию

Country Status (10)

Country Link
US (3) US20090131316A1 (ru)
EP (1) EP1941899A4 (ru)
JP (1) JP4180645B2 (ru)
KR (1) KR100996985B1 (ru)
CN (1) CN101272803B (ru)
AU (1) AU2006295785B2 (ru)
CA (1) CA2624123C (ru)
NZ (1) NZ567046A (ru)
RU (1) RU2388485C2 (ru)
WO (1) WO2007037413A1 (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5952967B2 (ja) 2013-06-12 2016-07-13 マルハニチロ株式会社 ジペプチジルペプチダーゼｉｖ（ｄｐｐｉｖ）阻害ペプチド化合物、それを含有する組成物、及びその製造方法
JP2017165661A (ja) * 2016-03-14 2017-09-21 雪印メグミルク株式会社 糖質代謝改善剤
EP3590519A4 (en) * 2017-03-03 2020-12-16 Morinaga Milk Industry Co., Ltd. GLP-1 SECRETAGOGUE AND COMPOSITION
KR101969719B1 (ko) 2017-07-04 2019-04-17 한남대학교 산학협력단 리시닐-프럭토오즈(Lysinyl-Fructose, LF)를 포함하는 혈당상승 억제제 및 그 제조방법
KR102043461B1 (ko) 2017-12-21 2019-11-11 주식회사 프로테인웍스 아스코르빈산 및 니아신을 포함하는 식후 혈당상승억제용 조성물
JP7146676B2 (ja) * 2019-03-15 2022-10-04 日清食品ホールディングス株式会社 分泌促進能評価試験方法
EP3960201A4 (en) * 2019-04-26 2023-01-25 Suntory Holdings Limited Composition for promoting glp-1 secretion
EP3916006A1 (en) 2020-05-26 2021-12-01 Consejo Superior de Investigaciones Científicas (CSIC) Peptides capable of inducing anorexic hormones, compositions and uses thereof
KR20230057134A (ko) 2021-10-21 2023-04-28 한가람비앤에프 주식회사 해죽순 추출물을 포함하는 식후 혈당상승억제용 조성물
KR102450000B1 (ko) 2022-02-20 2022-09-30 이용호 커피 추출물을 포함하는 식후 혈당상승억제용 조성물
KR20230174959A (ko) 2022-06-22 2023-12-29 농업회사법인 그린생명주식회사 아마도리 화합물을 고농도로 함유하는 홍삼 추출물을 포함하는 식후 혈당상승억제용 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968901A (en) * 1989-10-30 1999-10-19 Andersson; Bengt Antibacterial composition
JP2673320B2 (ja) * 1990-01-25 1997-11-05 雪印乳業株式会社 う蝕原菌付着阻止剤
CA2199707A1 (en) 1994-09-16 1996-03-21 Pradip Mukerji Inhibition of human rotavirus infection
NZ333652A (en) 1994-09-16 2000-07-28 Abbott Lab Inhibition of human rotavirus infection using kappa-casein
GB9927603D0 (en) 1999-11-22 2000-01-19 Nestle Sa Use of a milk protein hydrolysate in the treatment of diabetes
GB0116509D0 (en) * 2001-07-06 2001-08-29 Hannah Res Inst The Methods of extracting casein fractions from milk and caseinates and production of novel products
EP1367065B1 (en) * 2002-05-27 2008-07-30 Nestec S.A. Acid soluble proteins from micellar casein
US20040077530A1 (en) * 2002-10-18 2004-04-22 Robert Portman Composition for reducing caloric intake
JPWO2004050118A1 (ja) * 2002-11-29 2006-03-30 森永乳業株式会社 プロテアーゼ阻害剤
US7629442B2 (en) * 2003-08-30 2009-12-08 Nestec S.A. Acid soluble proteins from micellar casein

Also Published As

Publication number Publication date
US8114837B2 (en) 2012-02-14
US20090131316A1 (en) 2009-05-21
RU2388485C2 (ru) 2010-05-10
EP1941899A4 (en) 2009-11-11
KR100996985B1 (ko) 2010-11-26
US8367608B2 (en) 2013-02-05
KR20080043867A (ko) 2008-05-19
CA2624123C (en) 2011-11-15
JPWO2007037413A1 (ja) 2009-04-16
US20100144638A1 (en) 2010-06-10
WO2007037413A1 (ja) 2007-04-05
US20120108508A1 (en) 2012-05-03
NZ567046A (en) 2010-11-26
EP1941899A1 (en) 2008-07-09
AU2006295785A1 (en) 2007-04-05
CN101272803B (zh) 2012-11-21
AU2006295785B2 (en) 2009-10-29
HK1120440A1 (en) 2009-04-03
CA2624123A1 (en) 2007-04-05
CN101272803A (zh) 2008-09-24
JP4180645B2 (ja) 2008-11-12

Similar Documents

Publication Publication Date Title
PH12020551205A1 (en) Fap inhibitors
DE60327103D1 (de) Darreichungsformen enthaltend einen protonpumphemmer, einen nsaid und einen puffer
TW200505881A (en) Tri(cyclo) substituted amide compounds
EA200601747A1 (ru) Три(цикло)замещённые амидные соединения
PT1171465E (pt) Analogos de petido inibidor gastrico e sua utilizacao para o tratamento de diabetes
CL2016002589A1 (es) Uso del compuesto genz-112638 (eliglustat), inhibidor de glucosilceramida sintasa, en el tratamiento de la enfermedad de gaucher y enfermedad de fabry (divisional de solicitud 201201348).
NO20091700L (no) Florizinanaloger som inhibitorer av glukose-ko-transporter 2
ATE461217T1 (de) Glp-1-verbindungen
WO2006097536A3 (en) Dimeric peptide agonists of the glp-1 receptor
UA100111C2 (ru) Лечение диабета типа 2 комбинацией ингибитора dpiv и метформина или тиазолидиндиона
DK1546127T3 (da) Nye pyrimidinamidderivater og anvendelse deraf
RU2008116176A (ru) Стимулятор секреции глюкагон-подобного пептида 1, продукты питания или напитки, стимулирующие секрецию глюкагон-подобного пептида 1, ингибитор постпрандиальной гипергликемии и продукта питания или напитки, ингибирующие постпрандиальную гипергликемию
EA200701845A1 (ru) Рофлумиласт для лечения сахарного диабета
EA200601837A1 (ru) Бензоксазины для лечения заболеваний дыхательных путей
DK1781277T3 (da) Kombinationssammensætning, der omfatter Ibuprofen og Paracetamol
PL1622939T3 (pl) Aktywne warianty białka wiążącego IL-18 i ich medyczne zastosowania
MXPA06012143A (es) Arilsulfonamidas y usos relacionados con las mismas.
TW200621160A (en) Anti-termite agent
IL189286A0 (en) Novel cysteine protease inhibitors and their therapeutic applications
EA200200853A1 (ru) Применение 2-метилтиазолидин-3,3-дикарбоновой кислоты (2-мтдк) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака
MY128529A (en) Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
GEP20094854B (en) Compounds for treating diseases of impaired gastric motility
EA200801453A1 (ru) Комбинация биологически активных веществ фунгицидного действия
MY140538A (en) Substituted n-acyl-2-aminothiazoles
DE602004030265D1 (de) Behandlung von gastrointestinalen stromatumoren mit imatinib und midostaurin